硅胶植入物乳房手术后的磁共振成像筛查:患者对美国食品药品监督管理局建议依从性的调查
该研究调查了2011至2016年间接受硅胶乳房植入物手术的患者对FDA磁共振筛查建议的知晓与依从情况。在370例合格患者中109例接受电话调查,依从率仅5.9%(95%CI 0.15-28.7%),美容与重建手术、保险状态及收入水平间无差异。作者认为低依从性提示当前联邦监测建议的潜在局限,需进一步研究。
要点
- 硅胶乳房植入物患者对FDA磁共振筛查建议的依从率仅5.9%(95%CI 0.15-28.7%)。
- 美容与重建手术患者依从性无差异(p=1.00;OR 0.80;95%CI 1.17-2.93)。
- 有无医疗保险及居住县收入水平与依从性无显著关联。
核心结论
- 受访者中仅小部分按照FDA建议接受了磁共振成像筛查,低依从性凸显当前联邦监测建议的潜在局限,需进一步研究以明确依从性、实施障碍及建议是否仍然有效。
研究设计与样本
- 回顾性电子病历检索2011至2016年间年龄≥18岁、接受硅胶乳房植入物手术的患者,采用标准化电话脚本对同意参与者进行横断面调查,排除拒绝参与或无法联系者;计算单样本95%置信区间的比值比,行Fisher精确独立性检验及多变量逻辑回归分析混杂。
诊断标准与关键数值
- 对FDA建议的依从率为5.9%(95%CI 0.15-28.7%);美容手术与重建手术组依从性无差异(p=1.00;OR 0.80;95%CI 1.17-2.93)。
局限性
- 需额外研究以更好地描述对磁共振成像监测建议的依从性、识别实施障碍并确定该建议是否仍然有效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The U.S. Food and Drug Administration recommends women with silicone breast implants undergo magnetic resonance imaging surveillance to detect asymptomatic rupture. Screening is costly and often not covered by insurance. The authors assessed awareness of and adherence to these recommendations among patients with silicone breast implants.
METHODS: The authors searched electronic medical records for patients aged 18 years or older with silicone breast implants placed between 2011 and 2016. Consenting patients were surveyed by telephone using a standardized script to assess awareness of U.S. Food and Drug Administration recommendations, whether they had undergone magnetic resonance imaging screening, and barriers to testing. Patients who declined to participate or could not be contacted were excluded. Demographics and operative data were collected. Odds ratios were calculated with one-sample 95 percent confidence intervals, and Fisher exact tests of independence were conducted under assumptions of normality. Multivariable logistic regression analysis was performed to test for confounding.
RESULTS: Of 370 patients meeting inclusion criteria, 109 consented to participate. Adherence to U.S. Food and Drug Administration recommendations was 5.9 percent (95 percent CI, 0.15 to 28.7 percent). There was no difference in adherence between patients undergoing cosmetic versus reconstructive surgery ( p = 1.00; OR, 0.80; 95 percent CI, 1.17 to 2.93), having health insurance ( p = 0.58), or residing in a county with median annual household income greater than that of the state of residence ( p = 0.33).
CONCLUSIONS: A small proportion of respondents had undergone magnetic resonance imaging in accordance with U.S. Food and Drug Administration recommendations. Low adherence highlights a potential limitation of current federal surveillance recommendations. Additional research is needed to better characterize adherence to magnetic resonance imaging surveillance recommendations, identify barriers to implementation, and determine whether this recommendation remains valid.
引用
- Copeland-Halperin, Wampler, Doughty, et al. Magnetic Resonance Imaging Screening after Silicone Implant Breast Surgery: Patient Survey of Adherence to U.S. Food and Drug Administration Recommendations. Plast Reconstr Surg. 2022. PMID: 35653512. doi:10.1097/PRS.0000000000009317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。